02 May 2006
Karus Therapeutics appoints Simon Kerry as CEO
Karus Therapeutics, an emerging biotechnology company and University of Southampton spinout, focused on developing innovative therapeutics to treat cancer and heart disease, has announced the appointment of Simon Kerry as its Chief Executive Officer (CEO).
13 December 2005
Collaboration with Sareum Holdings
Karus Therapeutics is pleased to announce it has entered into a collaborative agreement with AIM-listed Sareum Holdings plc, a specialist structure-based drug discovery and services business. Sareum will provide computational chemistry expertise to support Karus's therapeutic discovery programmes based on inhibitors of histone deacetylase (HDAC). Financial terms of the agreement were not disclosed.
21 July 2005
Cancer and heart disease drug discovery company is latest spin-out from Southampton University
A new spin-out company from the University of Southampton is aiming to make the treatment of cancer and heart disease more patient friendly.